MYC and B-cell non-Hodgkin lymphoma: In support of our study, the mutation signature associated with FL was also the characteristic change in high-grade B-cell lymphoma with MYC and BCL2 translocations [46], and in the EZB or C3 genetic subgroup, which are enriched by BCL2 translocation [23, 24].